MYLAN 421 (Methyldopa 500 mg)

Pill imprint MYLAN 421 has been identified as Methyldopa 500 mg.

Methyldopa is used in the treatment of high blood pressure; hypertensive emergency and belongs to the drug class antiadrenergic agents, centrally acting. Risk cannot be ruled out during pregnancy. Methyldopa 500 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for MYLAN 421

Methyldopa 500 mg MYLAN 421 Front
Methyldopa 500 mg MYLAN 421 Back
Methyldopa 500 mg MYLAN 421
Methyldopa
Imprint:
MYLAN
421
Strength:
500 mg
Color:
Orange
Size:
19.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antiadrenergic agents, centrally acting
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-0421
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
hypromelloses
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
sodium lauryl sulfate
titanium dioxide
triacetin
FD&C Yellow No. 6
FD&C Blue No. 2
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0201 UDL Laboratories Inc

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)